BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Jan 03, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Status

JX-594: Phase Ib started

Jennerex Inc., San Francisco, Calif.
Lee's Pharmaceutical Holdings Ltd. (HKSE:0950), Hong Kong, China
Transgene S.A. (Euronext:TNG), Illkirch, France
Product: JX-594
Business: Cancer
Molecular target: Granulocyte macrophage colony-stimulating...

Read the full 110 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >